Sign up today to save time and keep current by receiving free, weekly science newsletters delivered directly to your inbox!
“I really enjoy your newsletters and look forward to receiving them.”
– Kathryn Futrega, B.Sc
Queensland University of Technology
“Thank you so much for your email and your great newsletters. My team and I really enjoy them, and I cover your “MSC news” in our group meeting each Monday.”
– Jan Nolta, PhD
Professor, UC Davis School of Medicine
“I often look forward to the weekly summaries from Connexon.”
– Kristopher Lofgren, PhD
Boston Children’s Hospital
“Great newsletter, especially like the weekly summary of articles in my field in my inbox so I don’t have to go looking for them.”
– Jennifer Adair, PhD, Fred Hutchinson Cancer Research Center and University of Washington
“I inadvertently got signed up for the newsletter. But because I found it so useful and informative, I have remained subscribed and actually recommended it to others.”
– Gregory Weber, PhD
Rutgers, The State University of New Jersey
“I have found these newsletters to be very valuable resources.”
– Dean Yamaguchi, MD, PhD
Associate Chief of Staff
VA Greater Los Angeles Healthcare System
About Cancer Stem Cell News
Since its launch in December 2012, Cancer Stem Cell News
has become a highly valued resource and provides readers with a unique compilation of cancer stem cell research findings across multiple tissue and cancer types. Connexon Creative recognizes that the cancer stem cell field is progressing rapidly, and takes pride in providing our subscribers with easy access to the most recent results, reviews and news in one place. By facilitating the exchange of cutting edge cancer stem cell publications and news, we keep scientists current while saving them valuable time.
This newsletter highlights the most recent publications covering research areas such as the identification and isolation of cancer stem cells, their proliferation and differentiation characteristics, gene expression and regulatory pathways, and the development of anti-cancer therapies. Our expert editorial team carefully selects the most recent, relevant peer-reviewed publications from high impact journals, as well as related press releases from key biotech and pharma companies. We also include cancer stem cell jobs and events hosted by leading research organizations, societies, and institutes.
Attracting more than 1,000 subscribers in its first year, Cancer Stem Cell News
has been one of Connexon Creative’s most successful newsletter launches and has clearly filled a niche within the cell biology research community. Our readership is composed of a diverse cohort of academic researchers, medical professionals, and individuals from the biotechnology and pharmaceutical industries whose work focuses on a variety of cell types, from hematopoietic to mammary cells, but who share a common interest in cancer initiation. In addition to providing researchers with a fantastic resource to keep current, we invite them to submit jobs, publications, press releases and events for possible inclusion by our editorial board at no cost.